Introduction: In-stent restenosis (ISR) has been one of the biggest limitations to the success
of percutaneous coronary intervention for the treatment of coronary artery disease (CAD) …

Coronary artery in-stent restenosis (ISR) is driven by neointimal hyperplasia and
neoatherosclerosis in previously placed stents. Drug eluting stents (DES) have been …

Stent failure remains the major drawback to the use of coronary stents as a revascularization
strategy. Recent advances in imaging have substantially improved our understanding of the …

Abstract Treatment of coronary in‐stent restenosis (ISR) is challenging and often requires
combination of multiple treatment modalities. Coronary intravascular lithotripsy (IVL) has …

Objective To examine the outcomes with intravascular brachytherapy (IVBT) in recurrent in-
stent restenosis (ISR). Background Recurrent ISR can be challenging to treat and IVBT can …

Coronary artery calcification is prevalent in coronary heart disease with its progression
being predictive of future adverse cardiac events. Its presence is considered to be a marker …

Background In-stent restenosis (ISR) has become a significant obstacle to interventional
therapy for atherosclerotic cardiovascular disease. The optimal percutaneous coronary …

Purpose To evaluate coronary artery integrity after very high radiation doses from
intravascular brachytherapy (IVBT) in the setting of source asymmetry. Methods Ten patients …

Intracoronary stent restenosis (ISR) is a clinically relevant challenge in the modern era.
Heterogeneity in patient-and lesion-specific factors can further compound this clinical …

Background Recurrent drug-eluting stents (DES) in-stent restenosis (ISR) can be
challenging to treat. The combined use of excimer laser atherectomy (ELCA) and vascular …